The Increasing Number Cases Related to Vitiligo to Foster the Growth of Global Vitiligo Treatment Market

Published: Mar 2022

The global vitiligo treatment market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2022-2028). The increasing disease prevalence for vitiligo across the globe is one of the prime factors affecting and driving the market for vitiligo treatment. As per the information provided by VR Foundation, Inc., in 2020 the total number of people suffering from vitiligo is estimated nearly 65-95 million people across the globe. Generally, vitiligo is related to autoimmune illnesses, also has a negative effect on hearing and eyesight, and is not related to any boundaries of race, ethnicity, or gender. However, various treatments, including topical creams and light therapy, can support some patients as well.

Browse the full report description of “Global Vitiligo Treatment Market Size, Share & Trends Analysis Report By Type (Non-Segmental Vitiligo, and Segmental Vitiligo), By Treatment (Therapy, Surgery, and Medication), and By End-User (Hospitals, and Aesthetic Clinics) Forecast, 2022-2028” at https://www.omrglobal.com/industry-reports/vitiligo-treatment-market

Moreover, to gain on the opportunity key players operating in the global vitiligo treatment market had been adopting strategies such as new launches to achieve major market share. For instance, in December 2021, Incyte Corp. had set forth that the U.S. Food and Drug Administration (FDA) had accepted for priority review for the supplemental New Drug Application (sNDA) that is ruxolitinib cream which is considered as a topical JAK inhibitor, for the purpose of providing effective treatment in adolescents and adults with vitiligo.

Market Coverage

  • The market number available for – 2021-2028
  • Base year- 2021
  • Forecast period- 2022-2028

Segment Covered- 

  • By Product
  • By Diagnosis
  • By Treatment

Regions Covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape- AVITA Medical, Incyte Corp., TWi Biotechnology, Dermavant Sciences, Inc., and Clinuvel Pharmaceuticals Ltd.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Vitiligo Treatment Market Report Segment 

By Type

  • Non-Segmental Vitiligo
  • Segmental Vitiligo

By Treatment

  • Therapy 
  • Surgery 
  • Medication

By End-User

  • Hospitals 
  • Aesthetic Clinics

Global Vitiligo Treatment Market Report Segment By Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa


To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/vitiligo-treatment-market